Global Head of Digital Trials in gBDS

Location: Ingelheim, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
Are you looking for a new professional challenge in a global acting company, would you like to utilize your expertise with digital devices and your experience in clinical trials?

This is a unique opportunity for you to use and advance your professional skills in a demanding international field of work by joining an international, growing and highly-motivated team.

Tasks & responsibilities

  • In your new role you lead collaboration with neighboring and enabling functions in the establishment and implementation of the Boehringer Ingelheim Digital Development Strategy for clinical trials and programs cross Therapeutic Areas. You are focusing on statistical, data collection via various sources and analytics aspects.
  • You are holding the key role in establishing overview and knowledge of available digital state of the art tools and approaches, servcies and tools. Furthermore, you serve as a global aggregative point for internal innovation and ideas in the field of use digital health in clinical trials.
  • As Global Head of Digital Trials gBDS (global Biostatistics & Data Sciences) you ensure feedback and assessment of the implemented tools and approaches for improvement and/or decision taking based on pre-defined metrics and lesson learned. You ensure that solutions identified maximize efficiencies.
  • In your range of duty, you consult and support Therapeutic Areas, trial teams in understanding, implementing and continous use of digital health technologies.

Requirements

  • Preferably Master degree in life/data sciences, information technology, and/or clinical development related majors or equivalent qualification
  • At least 5 years of relevant job experience
  • Familiarity with digital devices and their utilization in clinical trials and thorough understanding of processes and standards (e.g. Clinical Data Interchange Standards Consortium)
  • Ability to communicate and interact effectively with people internally and externally
  • Ability to strategic and economic thinking
  • Fluency in written and spoken English with excellent presentations skills

Apply for this job

About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...